CDXS Codexis, Inc.
Healthcare$2.60+4.42%ClosedMarket Cap: $236.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
5.23
P/S
2.90
EV/EBITDA
-15.71
DCF Value
$-3.55
FCF Yield
-9.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
83.9%
Operating Margin
-33.2%
Net Margin
-41.0%
ROE
-68.1%
ROA
-24.7%
ROIC
-22.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $15.2M | 78.3% | $-8.0M | $-8.7M | $— | — |
| Q4 null | $38.9M | 91.4% | $14.0M | $9.6M | $— | — |
| FY null | $70.4M | 86.7% | $-38.3M | $-44.0M | $— | — |
| Q3 null | $8.6M | 71.3% | $-18.9M | $-19.6M | $— | — |
| Q2 null | $15.3M | 77.8% | $-12.9M | $-13.3M | $— | — |
| Q1 null | $7.5M | 63.8% | $-20.5M | $-20.7M | $— | — |
| Q4 null | $21.5M | 83.0% | $-7.3M | $-10.4M | $— | — |
| FY null | $59.3M | 72.6% | $-58.5M | $-65.3M | $— | — |
| Q3 null | $12.8M | 66.4% | $-16.6M | $-20.6M | $— | — |
| Q2 null | $8.0M | 56.6% | $-22.7M | $-22.8M | $— | — |
| Q1 null | $17.1M | 64.2% | $-11.9M | $-11.5M | $— | — |
| Q4 2023 | $26.6M | 84.6% | $281.0K | $-7.2M | $-0.10 | — |